Conference Report, Part II

Our previous issue included an overview of the most
important practical treatment information from the Sixth
International Conference on AIDS, from a public talk by Marcus
Conant, M. D. This issue continues our Conference coverage:

* New discoveries of potential drugs outside of the dominant
preconceptions may offer the most promising possibilities for
future development -- because with them, the easy research has
not already been done. But these new developments risk being
ignored. Newspapers seldom acknowledge their existence, and few
scientists, physicians, or reporters have time to read or listen
to all the Conference presentations. Our article on experimental
antivirals examines two scientific papers which deserve
attention.

* Many Conference presentations concerned AZT dosage,
combination therapy, and antiviral resistance. The article by
Michelle Roland on AZT outlines these developments.

* Opportunistic infections are potentially easier to treat
than HIV, and yet they have often been neglected in the research
conducted up to now. As a result, advances against opportunistic
infections have been among the most practical of new
developments, and at the same time among the most disappointing.
In this issue, Denny Smith reviews cryptosporidiosis reports
presented at the Conference.